|
1
|
Scorzoni L, de Lucas MP, Mesa-Arango AC,
Fusco-Almeida AM, Lozano E, Cuenca-Estrella M, Mendes-Giannini MJ
and Zaragoza O: Antifungal efficacy during Candida krusei infection
in non-conventional models correlates with the yeast in vitro
susceptibility profile. PLoS One. 8:e600472013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gedik H, Şimşek F, Kantürk A, Yildirmak T,
Arica D, Aydin D, Demirel N and Yokuş O: Bloodstream infections in
patients with hematological malignancies: Which is more
fatal-cancer or resistant pathogens? Ther Clin Risk Manag.
10:743–752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shorr AF, Gupta V, Sun X, Johannes RS,
Spalding J and Tabak YP: Burden of early-onset candidemia: Analysis
of culture-positive bloodstream infections from a large U.S.
database. Crit Care Med. 37:2519–2526; quiz 2535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colombo AL, Tobón A, Restrepo A,
Queiroz-Telles F and Nucci M: Epidemiology of endemic systemic
fungal infections in Latin America. Med Mycol. 49:785–798.
2011.PubMed/NCBI
|
|
5
|
Arendrup MC: Epidemiology of invasive
candidiasis. Curr Opin Crit Care. 16:445–452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pemán J, Cantón E, Quindós G, Eraso E,
Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT,
Pérez-del-Molino L, Linares-Sicilia MJ, et al: Epidemiology,
species distribution and in vitro antifungal susceptibility of
fungaemia in a Spanish multicentre prospective survey. J Antimicrob
Chemother. 67:1181–1187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pushpanathan M, Rajendhran J, Jayashree S,
Sundarakrishnan B, Jayachandran S and Gunasekaran P: Direct cell
penetration of the antifungal peptide, MMGP1, in Candida albicans.
J Pept Sci. 18:657–660. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oliveira VK, Lda S Ruiz, Oliveira NA,
Moreira D, Hahn RC, Melo AS, Nishikaku AS and Paula CR: Fungemia
caused by Candida species in a children's public hospital in the
city of São Paulo, Brazil: Study in the period 2007–2010. Rev Inst
Med Trop Sao Paulo. 56:301–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leroy O, Gangneux JP, Montravers P, Mira
JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B,
et al: Epidemiology, management, and risk factors for death of
invasive Candida infections in critical care: A multicenter,
prospective, observational study in France (2005–2006). Crit Care
Med. 37:1612–1618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bassetti M, Taramasso L, Nicco E, Molinari
MP, Mussap M and Viscoli C: Epidemiology, species distribution,
antifungal susceptibility and outcome of nosocomial candidemia in a
tertiary care hospital in Italy. PLoS One. 6:e241982011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Muñoz P, Sánchez-Somolinos M, Alcalá L,
Rodríguez-Créixems M, Peláez T and Bouza E: Candida krusei
fungaemia: Antifungal susceptibility and clinical presentation of
an uncommon entity during 15 years in a single general hospital. J
Antimicrob Chemother. 55:188–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abbas J, Bodey GP, Hanna HA, Mardani M,
Girgawy E, Abi-Said D, Whimbey E, Hachem R and Raad I: Candida
krusei fungemia. An escalating serious infection in
immunocompromised patients. Arch Intern Med. 160:2659–2664. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang J, Hao D and Chen Y, Xu Y, Tan J,
Huang Y, Li F and Chen Y: Inhibitory effects and mechanisms of
physiological conditions on the activity of enantiomeric forms of
an α-helical antibacterial peptide against bacteria. Peptides.
32:1488–1495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gopal R, Seo CH, Song PI and Park Y:
Effect of repetitive lysine-tryptophan motifs on the bactericidal
activity of antimicrobial peptides. Amino Acids. 44:645–660. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv Y, Wang J, Gao H, Wang Z, Dong N, Ma Q
and Shan A: Antimicrobial properties and membrane-active mechanism
of a potential α-helical antimicrobial derived from cathelicidin
PMAP-36. PLoS One. 9:e863642014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simon JP and Aunis D: Biochemistry of the
chromogranin A protein family. Biochem J. 262:1–13. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Helman LJ, Ahn TG, Levine MA, Allison A,
Cohen PS, Cooper MJ, Cohn DV and Israel MA: Molecular cloning and
primary structure of human chromogranin A (secretory protein I)
cDNA. J Biol Chem. 263:11559–11563. 1988.PubMed/NCBI
|
|
18
|
Lugardon K, Raffner R, Goumon Y, Corti A,
Delmas A, Bulet P, Aunis D and Metz-Boutigue MH: Antibacterial and
antifungal activities of Vasostatin-1, the N-terminal fragment of
chromogranin A. J Biol Chem. 275:10745–10753. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lugardon K, Chasserot-Golaz S, Kieffer AE,
Maget-Dana R, Nullans G, Kieffer B, Aunis D and Metz-Boutigue MH:
Structural and biological characterization of chromofungin, the
antifungal chromogranin A-(47–66)-derived peptides. J Biol Chem.
276:35875–35882. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li RF, Lu YL, Lu YB, Zhang HR, Huang L,
Yin Y, Zhang L, Liu S, Lu Z and Sun Y: Antiproliferative effect and
characterization of a novel antifungal peptide derived from human
chromogranin A. Exp Ther Med. 10:2289–2294. 2015.PubMed/NCBI
|
|
21
|
Li RF, Yan XH, Lu YB, Lu YL, Zhang HR,
Chen SH, Liu S and Lu ZF: Anti-candidal activity of a novel peptide
derived from human chromogranin A and its mechanism of action
against Candida krusei. Exp Ther Med. 10:1768–1776. 2015.PubMed/NCBI
|
|
22
|
Roilides E, Lyman CA, Sein T, Gonzalez C
and Walsh TJ: Antifungal activity of splenic, liver and pulmonary
macrophages against Candida albicans and effects of macrophage
colony-stimulating factor. Med Mycol. 38:161–168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Petraitiene R, Petraitis V, Groll AH,
Candelario M, Sein T, Bell A, Lyman CA, McMillian CL, Bacher J and
Walsh TJ: Antifungal activity of LY303366, a novel echinocandin B,
in experimental disseminated candidiasis in rabbits. Antimicrob
Agents Chemother. 43:2148–2155. 1999.PubMed/NCBI
|
|
24
|
Bideskan AR Ebrahimzadeh, Nikravesh MR,
Hassanzadeh Taheri MM and Fazel AR: Lectin histochemical study of
vasculogenesis during rat pituitary morphogenesis. Iran J Basic Med
Sic. 14:161–169. 2011.
|
|
25
|
Ding Y, Tang J, Zou J, She R, Wang Y, Yue
Z, Tian J, Xia K, Yin J and Wang D: The effect of microgravity on
tissue structure and function of rat testis. Braz J Med Biol Res.
44:1243–1250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prescott ML, Harley PJ and Klein AD:
Microbiology. 5th edition. McGraw-Hill Companies, Inc.; New York,
NY: pp. 9492002
|
|
27
|
Pfaller MA and Diekema DJ: Epidemiology of
invasive mycoses in North America. Crit Rev Microbiol. 36:1–53.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuang SY, Xiao WW, Feng L, Liu Y, Jiang J,
Jiang WD, Hu K, Li SH, Tang L and Zhou XQ: Effects of graded levels
of dietary methionine hydroxy analogue on immune response and
antioxidant status of immune organs in juvenile Jian carp (Cyprinus
carpio var. Jian). Fish Shellfish Immunol. 32:629–636. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Erdogan H, Fadillioğlu E, Kotuk M, Iraz M,
Tasdemir S, Oztas Y and Yildirim Z: Effects of ginkgo biloba on
plasma oxidant injury induced by bleomycin in rats. Toxicol Ind
Health. 22:47–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
